Dilip Shanghvi

The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharma in 1983 to make psychiatric drugs.The company is the world's fourth largest speciality generics maker and India's most valuable pharma outfit with March 2018 revenues of $3.6 billion.He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.His fortune was hit when Sun's shares fell in January 2019 after a whistleblower reported alleged corporate governance lapses to the market regulator.